LATEST NEWS

A new approach that targets young immune cells may also work for creating vaccines against the flu, dengue, malaria and hepatitis C
Seqster research portal empowers study participants to instantly collect & share medical records and genomic data with researchers
The award is given annually to a former Cancer Research Institute postdoctoral fellow in recognition of outstanding success in academia or industry for research that has had a major impact in the field of immunology.
Northern Trust wealth management executive Paul Thiel joins Institute Board
Detailed structural studies provide blueprint for the development of potent therapeutics and vaccines
LJI researchers reveal how the finely tuned balance between DNA methylation and demethylation prevents genomic instability and cancer
LJI team finds that ‘doublet’ immune cells are much more common—and more important in disease—than previously thought
LJI’s new understanding of killer T cells inspires clinical studies of potential immunotherapies
Former President of Cardinal Health China and long-term supporter of the Institute’s mission brings international healthcare expertise and a passion for life sciences
The grant establishes the global Viral Immunotherapeutic Consortium to develop new treatments for Ebola, Lassa and other viral threats
La Jolla Institute mourns passing of former Board member